Trial intelligence / Profile preview

Phase 2 trial of SaiLuoTong for mild-to-moderate vascular dementia

ChiCTR-TRC-14004613Phase 2Completed

Sponsor
Xuanwu Hospital
Start
Sep 2014
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of sailuotong in vascular dementia (3 arms), sponsored by Xuanwu Hospital. Primary endpoints: V-ADAS-cog and ADCS-CGIC. Started Sep 2014; status: completed.

02

Drugs

sailuotong
03

Conditions

vascular dementia

Beyond the preview

Go deeper on ChiCTR-TRC-14004613.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14004613.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call